Nguyen N L, Moulia-Pelat J P, Cartel J L
Institut Territorial de Recherches Médicales Louis Malardé, Papeete, Tahiti, French Polynesia.
Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):689-91. doi: 10.1016/s0035-9203(96)90439-3.
Community treatment with ivermectin was implemented in Opoa, French Polynesia from April 1991 to October 1993. All consenting inhabitants aged 3 years or more were treated with twice-yearly single doses of ivermectin, pregnant women excepted. A dosage of 100 microgram/kg was used for the 3 first treatments and then abandoned because it did not reduce the prevalence of microfilariae (mf) carriers. With a dosage of 400 micrograms/kg dosage, this prevalence decreased dramatically from 21% to 7%, and the mf level in carriers dropped to only 0.5% of its initial value after 3 treatments. The 400 micrograms/kg dosage was well tolerated and compliance was excellent. The twice-yearly single dose strategy with ivermectin at 400 micrograms/kg is safe and highly effective for filariasis control in an endemic area.
1991年4月至1993年10月期间,法属波利尼西亚的奥波阿实施了伊维菌素社区治疗。所有3岁及以上同意参与的居民每半年接受一次单剂量伊维菌素治疗,但孕妇除外。前3次治疗使用的剂量为100微克/千克,后因该剂量未降低微丝蚴(mf)携带者的患病率而被弃用。采用400微克/千克的剂量后,该患病率从21%大幅降至7%,携带者的mf水平在3次治疗后降至初始值的仅0.5%。400微克/千克的剂量耐受性良好,依从性极佳。每半年一次单剂量400微克/千克伊维菌素的治疗策略对于流行地区的丝虫病控制是安全且高效的。